By David Tuller, DrPH Sometimes I just like to post about a few things that have caught my interest, for whatever reason. I keep meaning to do this more regularly. Science For ME calls on Cochrane to retract flawed exercise review The Science for ME (S4ME) forum has posted a petition on change.org requesting that …
By David Tuller, DrPH I’ve said it before and will undoubtedly say it again. Trudie Chalder, King’s College London’s mathematically and factually challenged professor of cognitive behavior therapy (CBT), is a one-trick pony. She writes what is essentially the same bad paper based on the same unfounded assumptions over and over again. Her apparent professional …
Trial By Error: Just the Latest Gibberish from Professor Chalder Read More »
By David Tuller, DrPH Professor Chris Ponting is a geneticist at the University of Edinburgh. He is also the principal investigator for DecodeME, a genome wide association study. The DecodeME team recently published findings from more than 17,000 questionnaires it had collected from patients. I wrote about those findings in a post last week. In …
Trial By Error: Professor Chris Ponting Discusses on DecodeME’s First Results Read More »
By David Tuller, DrPH Update: The post indicates that more than 17,000 people had submitted the DecodeME questionnaire. Actually, as of the most recent count this month, DecodeME has now received more than 23,000 questionnaires. DecodeME paper finds ME/CFS severity linked to being female, being older and being sick longer DecodeME is a high-profile genome-wide …
By David Tuller, DrPH The Journal of Neurology, Neurosurgery, and Psychiatry (JNNP) has finally published a cogent rapid response to its recent whine de coeur from the PACE authors and their cronies. In the commentary, the co-authors criticized eight purported “anomalies” they believe occurred during the process of developing the 2021 ME/CFS guideline from Britain’s …
By David Tuller, DrPH I recently wrote about a Dutch study published a few months ago in the journal Clinical Infectious Diseases–“Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial.” The study, nick-named ReCOVer, found that unblinded trials relying on subjective outcomes will produce modestly positive reports …
